Available Technologies
PHARMA & DRUGS
(for more information, click title to open PDF file)
A-04 Pharmaceutical Composition for Treatment or Prevention of Liver Cancer
Nagoya University is currently seeking companies interested in commercializing a novel pharmaceutical composition for treatment or prevention of liver cancer.
A-05 Novel Therapeutic Strategy for B Cell Malignant Lymphocyte
Nagoya University is seeking companies interested in commercializing a novel therapeutic strategy for B cell malignant lymphocyte resistant to Rituximab.
A-06 Anti-Polyglutamine Disease Agent
Nagoya University is actively seeking companies interested in commercializing a novel method to inhibit and digest an aggregating protein such as an androgen receptor (AR) having an abnormally extended polyglutamine chain.
A-10 New Therapeutic Agents for Obesity: GABAB Agonist
Baclofen, a GABAB agonist, has been used to treat muscle stiffness in patients with multiple sclerosis or cerebral palsy without apparent side effects.
A-11 Neuronal Cell Death Inhibitor and Screening Method
The technology provides a neuronal cell death inhibitor comprising a compound having an inhibitory activity on the production and/or release of glutamate in activated microglia.
A-14 (-) Ternatin: A Potent Compound for Obesity
Obesity has attracted significant attention as a serious public-health problem.
A-15 Novel Cancer Therapy Drug - Microtubule Disrupting Agent
Researchers at Nagoya University have found that a component of Ginger, 6-Shogaol, disrupts microtubule polymerization and inhibits the proliferation of cancer cells.
A-16 Novel Agent to Assist Cancer Treatment
Researchers at Nagoya University have identified a novel agent which will overcome the treatment failure of drug resistant cancers.
A-17 Archaeal Proteasome to Digest Human Aggregating Proteins
Researchers at Nagoya University have identified that an archaeal proteasome is useful for digesting an aggregating protein such as mutant superoxide dismutase 1 (SOD1) or an androgen receptor (AR) having an abnormally extended polyglutamine chain in human cells.
A-18 Novel Method to Produce Mesenchymal Stem Cells
Researchers at Nagoya University have developed a novel method to produce mesenchymal stem cells.
A-21 Effective Method to Produce Multipotential Stem Cells from Adipose Tissues
Researchers at Nagoya University have developed an effective method to collect and produce large amounts of multipotential stem cells (MSCs) derived from human adipose tissues.
A-24 Enzymatic Assay of D-Serine
D-serine functions as a co-agonist of the N-methylic-D-aspartic acid (NMDA) receptor in the mammalian brain.
A-25 Method for Measuring Polyamines in Erythrocytes
Polyamines are growth factor having a very simple structure and which interact with certain acidic high-molecular materials to exhibit various physiological activities.
A-29 A Novel Method to Detect Virus-Infections from Blood
The Epstein-Barr virus (EBV) is a member of the herpes virus family, which includes herpes simplex virus 1 and 2, and is one of the most common viruses in humans.
A-30 Novel Drug Delivery System Using Electroporation
Researchers at Nagoya University have invented a new drug delivery system using a novel electrode.
A-31 Novel Drug Candidate for Neurodegenerative Diseases
Researchers at Nagoya University and Meijo University have synthesized a novel neurotrophic factor (NGF)-enhancing compound, which shows memory recovery effects on aged mice and senescence-accelerated mice (SAM).
A-32 Cell Therapy for Neurogenic Bladder
Researchers at Nagoya University have developed a novel medical use of adipose-derived mesenchymal stem cells (ADSCs) for neurogenic bladder therapy.
A-42 DAMTS-4: Therapeutics to Functionally Recover the Injured Spinal Cord
A damaged central nervous system (CNS) usually does not recover again.
A-43 RVG-CpG: A Brain-Permeable Nucleic Acid for Alzheimer's Disease Treatment
With the progress of an increasingly aging society, the number of patients with Alzheimer's disease continues to increase.
A-46 Cancer Cell Proliferation Inhibitor
Researchers at Nagoya University reported for the first time in the world that the thyroid transaction factor-1 (TTF-1) gene is involved in peripheral lung differentiation and contributes as a master regulatory factor of cell differentiation.
A-49 Use of Ribavirin in Blood Coagulation Disorder
Blood coagulation disorder (also called bleeding disorder) produces prolonged or excessive bleeding.
A-50 A Novel Therapeutic Agent for Inflammatory Arthritis
Non-steroidal anti-inflammatory drugs such as Aspirin and Ibuprofen have been used for a long time in the treatment of inflammatory arthritis, although they have gastrointestinal and renal adverse effects.
A-52 Adiponectin for Treatment of Ventricular Fibrillation and Myocardial Infarction
Myocardial infarction (MI) is a major cause of sudden cardiac death in industrial countries.
A-54 Anti-Tumor Aqueous Solution
Atmospheric plasma technology has been recently collecting more attention.
